Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agrylin Post‑marketing Drug Use-Result Survey in Essential Thrombocythemia
jRCT2031210640Completed
- Sponsor
- Takeda
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of anagrelide in thrombocythemia, sponsored by Takeda. Primary endpoints: Number of participants with one or more adverse events, Number of participants with one or more serious adverse events and 4 more. Started Nov 2014; status: completed.
02
Drugs
anagrelide
03
Conditions
thrombocythemia
Beyond the preview
Go deeper on jRCT2031210640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210640.